期刊文献+

自身免疫性疾病与自身抗体概述 被引量:3

An overview of autoimmune diseases and autoantibodies
下载PDF
导出
摘要 自身免疫性疾病(AD)是一种慢性疾病,通常由丧失对自身抗原的免疫耐受性引起,可累及单一器官或多个器官和系统。近年来对AD的研究使人们对其理解不断深入,并确立了更详细和精确的分类和诊断方法,在此基础上有望建立更先进的医疗手段。本文将结合近期的一些研究进展,围绕AD的不同发病因素、发病机制、自身抗体特征及相应治疗方法进行系统介绍。 Autoimmune disease(AD)refers to a type of chronic disease,caused by the lack of immune tolerance to autoantigens,which can endanger specific target organs or multiple organs and systems. In recent years,researches on AD have greatly deepened people′s understanding of it,and established more detailed and accurate classification and diagnosis methods. Based on this,it is expected to establish more advanced medical methods. Here,we will introduce the latest research progress,and systematically introduce the different pathogenesis and causes of AD,as well as the characteristics of autoantibody and corresponding treatment methods.
作者 钱嘉航 任军 贾凌云 姬芳玲(指导) QIAN Jiahang;REN Jun;JIA Lingyun;JI Fangling(Dalian University of Technology,School of Bioengineering,Dalian 116024,China)
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2022年第17期2152-2158,共7页 Chinese Journal of Immunology
基金 国家自然科学基金青年基金项目(21506025)。
关键词 自身免疫性疾病 自身抗体 免疫球蛋白 血液净化 Autoimmune diseases Autoantibodies Immunoglobulin Blood purification
  • 相关文献

参考文献3

二级参考文献38

  • 1段维佳,贾继东.2010年美国肝病学会原发性硬化性胆管炎指南解读[J].中国医学前沿杂志(电子版),2011,3(1):4-7. 被引量:5
  • 2尹爱武,谭凌,朱付凡.aCL阳性流产患者治疗120例报告[J].中国医学工程,2004,12(5):97-99. 被引量:2
  • 3Wallace DJ, Hahn B. Dubois' lupus erythematosus[M]. Lippincott Williams & Wilkins, 2007.
  • 4曾小峰.第十一次全国临床流行病学学术会议论文集:中国系统性红斑狼疮(SLE)的注册研究:来自CSTAR(中国系统性红斑狼疮研究协作组)的初步数据分析[C].烟台,2011:141.
  • 5Groom J, Kalled SL, Cutler AH, et al. Association of BAFF/BLyS overexpression and altered B cell differen- tiation with Sjogren's syndrome[J]. J Clin Invest, 2002, 109(1): 59-68.
  • 6Wofsy D, Isenberg DA, Licu D, et al. Efficacy and safety of atacicept for prevention of flares in subjects with moderate to severe systemic lupus erythematosus (SLE)[J]. Arthritis Rheum, 2013, 65(S10): S675.
  • 7Hsu H, Khare SD, Lee F, et al. A novel modality of BAFF-specific inhibitor AMG623 peptibody reduces B- cell number and improves outcomes in murine models of autoimmune disease [J]. Clin Exp Rheumatol, 2011, 30(2): 197-201.
  • 8Furie RA, Thomas M, Chu A, et al. Effects of blisibi- mod, an inhibitor of B cell activating factor, on serum immunoglobulins and infection risk in patients with systemic lupus erythematosus:observations from the placebo-controlled Pearl-SC and open-label extension studies[J]. Arthritis Rheum, 2013, 65(S10): S739-40.
  • 9Merrill JT, Ginzler EM, Wallace DJ, et al. Long- term safety profile of belimumab plus standard therapy in patients with systemic lupus erythematosus [J]. Arthritis Rheum, 2012, 64(10): 3364-73.
  • 10Schmitt C, Roth D, Birch H. Efficacy of belimumab in systemic lupus erythematosus patients with high disease activity in key organ systems: BLISS sub-population[J]. Ann Rheum Dis, 2013, 72(Supp13): 90.

共引文献11

同被引文献34

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部